Navigation Links
Dr. Karol Sikora Accepts Appointment to MEI Healthcare Group's Board of Directors
Date:7/19/2011

CORAL SPRINGS, Fla., July 19, 2011 /PRNewswire/ -- MEI Healthcare Group, a leading provider of healthcare strategies and equipment solutions to medical facilities around the world, announced today that Dr. Karol Sikora has accepted an appointment to the company's board of directors. Sikora is the medical director of CancerPartnersUK, the largest independent cancer network in the UK, and is dean of medicine at the University of Buckingham, Britain's first independent medical school. Sikora was previously Chief of the World Health Organization's cancer programme and served as professor and chairman of the Department of Cancer Medicine at Imperial College School of Medicine. He is currently an honorary consultant oncologist at Hammersmith Hospital in London, where he served as clinical director for cancer services for 12 years, and is a fellow of Corpus Christi College in Cambridge.

"We are delighted to have Professor Sikora as a member of our board. His vision and experience on the international stage in both the public and private sectors will be a major asset to the MEI Healthcare Group," said MEI board chair Dr. Arthur Porter.

While serving at Hammersmith Hospital, Sikora chaired that facility's fundraising campaign, an appeal that raised 8m pounds Sterling to construct the Cancer Centre at Hammersmith.  Later, he became vice president for Pharmacia Corporation and managed the company's global clinical research for oncology. He is currently an adviser to the World Health Organization, the International Atomic Energy Agency (IAEA) and is a member of the UK Health Department's Expert Advisory Group on Cancer.

Sikora has published more than 300 papers and written or edited 20 books including Treatment of Cancer - the standard British postgraduate textbook now in its fifth edition and, most recently, The Economics of Cancer Care.  He is on the editorial board of several journals and is the founding editor of Gene Therapy and Cancer Strategy.

MEI provides business development, capital equipment funding strategies and growth consulting services to physicians, hospitals and healthcare systems worldwide.

About MEI Healthcare Group

Headquartered in Coral Springs, Fla., MEI is a comprehensive healthcare strategy firm that works with physician groups and medical centers to provide turnkey healthcare solutions. MEI and its subsidiaries, MEI Development Corporation, MEI Healthcare Capital, MEI Informatics, MEI Healthcare International and MEI Healthcare Foundation, offer its clients more than 40 years of healthcare business experience and the value-added benefits of its strategic alliances. For more information, visit http://www.mei.com

CONTACT:
Tyler Lecceadone
SeyferthPR
1-800-435-9539
Lecceadone@seyferthpr.com


'/>"/>
SOURCE MEI Healthcare Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Karolinska Development to Divest Portfolio Company
2. Karolinska University Hospital Acquires Leksell Gamma Knife Perfexion to Expand Radiosurgery Versatility, Efficiency in Brain Cancer Therapy
3. Karolinska Development: EMEA Recommends Orphan Drug Designation for Acute Myeloid Leukemia Treatment
4. Karolinska Development New Share Issue Completed - Raising 380 MSEK (36 MEUR)
5. Karolinska Development Portfolio Company Launches GMP Facility for Particulate Manufacturing
6. Karolinska Institutet to Test Vicals Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
7. Karolinska Institute to Test Vicals Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
8. FDA Accepts Endo Pharmaceuticals Complete Response for New Formulation of OPANA® ER
9. FDA Formally Accepts Dune Medicals MarginProbe™ System Pre-Market Approval (PMA) Application and Grants Expedited Review Status
10. Paul Meade Accepts Invitation to Speak at AACE Annual Meeting
11. FDA Accepts Investigational New Drug Application for ARI-3030MO; First in Man Clinical Trial to Begin During First Quarter of 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... Interpace Diagnostics Group, Inc., (NASDAQ: IDXG ... tests and pathology services for evaluating risks of cancer, ... January 13, 2017 from the NASDAQ Listing Qualifications notifying ... requirement of the NASDAQ Stock Market to maintain a ... The letter noted that for the last 10 ...
(Date:1/17/2017)... Jan 17, 2017 Research and Markets has announced ... report to their offering. ... This unique and comprehensive report, identifies and profiles the leading 200 ... across the globe from the United States and ... China . Profile information for each ...
(Date:1/17/2017)... LONDON , January 17, 2017 ... Review, 2016;11(Suppl. 1):2-4 ; http://www.touchneurology.com/articles/tailored-temperature-management-neurocritical-care ... ... Published recently in European ... from touchNEUROLOGY, Catherine Amey reports that ...
Breaking Medicine Technology:
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... a point of difference. Eden Activewear is a stand-out company for several differences ... exclusively online and only manufacture on demand, this is called 'Agile' manufacturing - ...
(Date:1/17/2017)... ... 2017 , ... Healthful Balance announces the national release of ... by Ed Stroup, was created to offer the highest quality vitamins and supplements ... service. Healthful Balance products can be purchased online through their website, or can ...
(Date:1/17/2017)... ... January 17, 2017 , ... Etymotic Research will demonstrate ... Music Merchants (NAMM) winter trade show, Booth #2876, at the Anaheim Convention Center ... been the gold standard for high-definition, in-ear earphones. This classic earphone has been ...
(Date:1/17/2017)... ... January 17, 2017 , ... Mirror Mirror Beauty Boutique, Houston’s ... of Diamond Level in Zeltiq’s Crystal Rewards Program. Practice founder, Paul Vitenas, MD FACS, ... group of providers. , Produced by Zeltiq, CoolSculpting is approved by the Food ...
(Date:1/17/2017)... ... January 17, 2017 , ... Surgeons from New ... eye care practitioners on the latest breakthroughs in the prevention, diagnosis and treatment ... Symposium, according to eye surgeon, Jeffrey Martin, MD, FACS, Chief Executive Officer of ...
Breaking Medicine News(10 mins):